Revvity Total Current Liabilities 2010-2024 | RVTY
Revvity total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Revvity total current liabilities for the quarter ending December 31, 2024 were $0.653B, a 54.97% decline year-over-year.
- Revvity total current liabilities for 2024 were $0.653B, a 54.97% decline from 2023.
- Revvity total current liabilities for 2023 were $1.45B, a 6.09% decline from 2022.
- Revvity total current liabilities for 2022 were $1.544B, a 27.25% increase from 2021.
| Revvity Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $653 |
| 2023 | $1,450 |
| 2022 | $1,544 |
| 2021 | $1,214 |
| 2020 | $1,652 |
| 2019 | $763 |
| 2018 | $772 |
| 2017 | $951 |
| 2016 | $603 |
| 2015 | $561 |
| 2014 | $597 |
| 2013 | $603 |
| 2012 | $581 |
| 2011 | $599 |
| 2010 | $515 |
| 2009 | $497 |
| Revvity Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $653 |
| 2024-09-30 | $688 |
| 2024-06-30 | $1,390 |
| 2024-03-31 | $1,374 |
| 2023-12-31 | $1,450 |
| 2023-09-30 | $1,448 |
| 2023-06-30 | $1,367 |
| 2023-03-31 | $1,564 |
| 2022-12-31 | $1,544 |
| 2022-09-30 | $1,486 |
| 2022-06-30 | $1,044 |
| 2022-03-31 | $1,263 |
| 2021-12-31 | $1,214 |
| 2021-09-30 | $1,145 |
| 2021-06-30 | $1,123 |
| 2021-03-31 | $1,521 |
| 2020-12-31 | $1,652 |
| 2020-09-30 | $1,245 |
| 2020-06-30 | $1,163 |
| 2020-03-31 | $730 |
| 2019-12-31 | $763 |
| 2019-09-30 | $1,188 |
| 2019-06-30 | $707 |
| 2019-03-31 | $742 |
| 2018-12-31 | $772 |
| 2018-09-30 | $687 |
| 2018-06-30 | $713 |
| 2018-03-31 | $926 |
| 2017-12-31 | $951 |
| 2017-09-30 | $598 |
| 2017-06-30 | $589 |
| 2017-03-31 | $601 |
| 2016-12-31 | $603 |
| 2016-09-30 | $548 |
| 2016-06-30 | $561 |
| 2016-03-31 | $555 |
| 2015-12-31 | $561 |
| 2015-09-30 | $554 |
| 2015-06-30 | $574 |
| 2015-03-31 | $551 |
| 2014-12-31 | $597 |
| 2014-09-30 | $567 |
| 2014-06-30 | $579 |
| 2014-03-31 | $605 |
| 2013-12-31 | $603 |
| 2013-09-30 | $589 |
| 2013-06-30 | $563 |
| 2013-03-31 | $573 |
| 2012-12-31 | $581 |
| 2012-09-30 | $582 |
| 2012-06-30 | $588 |
| 2012-03-31 | $603 |
| 2011-12-31 | $599 |
| 2011-09-30 | $876 |
| 2011-06-30 | $559 |
| 2011-03-31 | $511 |
| 2010-12-31 | $515 |
| 2010-09-30 | $514 |
| 2010-06-30 | $514 |
| 2010-03-31 | $498 |
| 2009-12-31 | $497 |
| 2009-09-30 | $513 |
| 2009-06-30 | $497 |
| 2009-03-31 | $469 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.032B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| Natera (NTRA) | United States | $20.018B | 0.00 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Doximity (DOCS) | United States | $9.934B | 51.66 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| HealthEquity (HQY) | United States | $7.311B | 35.97 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |